PLUVICTO® is the first and only RLT (radioligand therapy) for PSMA+ mCRPC. PLUVICTO® is not chemotherapy. RLT is a different type of radiation therapy that is injected and that targets a biomarker called PSMA, which is present on many prostate cancer cells and also some healthy cells. PLUVICTO® is designed to find and attack PSMA+ cells, including cancer cells.
If you are PSMA+, PLUVICTO® could be right for you. You can find out
if you are PSMA+ by having an imaging test called a PSMA-PET scan.
PLUVICTO® is given in up to 6 doses. Doses are given once every 6 weeks through an intravenous (IV) injection or infusion.
While on treatment with PLUVICTO®, a team of doctors will work together to make sure you are taken care of. You will also get support from nurses and other health professionals.
Before each dose:
After each dose:
Your body, blood, sweat, and urine give off radiation for a while after
getting PLUVICTO®. Always follow your doctor’s instructions.
Also, here are some tips to help reduce overall exposure to yourself and others:
It’s normal to have concerns about side effects when starting a new treatment. Speak with your care team about any side effects you may be experiencing. You should also ask any questions you may have. The most common side effects of PLUVICTO® include:
PLUVICTO® marks provided courtesy of Novartis
Archbold is pleased to welcome nurse practitioner Breanna Slaughter, ACNPC-AG, to the medical staff. Slaughter earned a Bachelor of Science degree in ...
Breast cancer remains the most common cancer among women other than skin cancer. It’s the second-leading cause of cancer death; about one in eight ...
The holiday season brings the warmth of family, the joy of tradition, and the anticipation of cherished moments with family and loved ones. But for ...
Archbold is pleased to announce the addition of Cecilie Cowie, FNP-C, to the Lewis Hall Singletary Archbold Cancer Center medical staff. Cowie earned ...
Live Better, the Archbold-led community health initiative, is hosting the 9 th annual Live Better Pink Run, which includes a 5K and 1-mile fun run for ...
Navigating your healthcare journey can feel overwhelming, especially when faced with a new diagnosis or trying to manage treatment plans. But patient ...
Breast cancer is something that crosses the minds of many women - and even some men - especially as we hear more about it and learn how common it can ...
Colorectal cancer, often dubbed the silent killer, doesn't always come with early warning signs. However, there are ways you can lower your risk and ...
Lung cancer affects thousands each year, but screenings can make a real difference. Detecting lung cancer early is essential, especially for those at ...
Archbold is pleased to welcome hematologist and medical oncologist Sheetal Higbee, MD, to the medical staff. Higbee earned a Bachelor of Science ...